Obesity, a persistent metabolic state characterized by an excess accumulation of adipose tissue, has emerged as a global ...

Roche said on Wednesday the promising results of an early-stage trial of its experimental weight-loss pill that bolstered its ...

Australian researchers said that supervised diets with intermittent fasting were for children with serious health conditions, ...

BioAge Labs Inc., a clinical-stage biotechnology company developing therapies for obesity and metabolic disease, is seeking ...

Shares in Roche dropped to a two-month low on Thursday after an experimental weight-loss pill that carries high market hopes ...

Data from an early stage clinical trial suggests Novo Nordisk’s new weight loss pill amycretin could produce greater and more ...

Obesity-focused biotech BioAge Labs said on Wednesday it was seeking a valuation of as much as $587 million in its initial ...

Children who used the weight loss drug liraglutide in a late-stage trial lost significantly more weight than children who got ...

Children with hidradenitis suppurativa (HS) are more likely to have obesity than those without the condition, a review ...

Alzheimer’s disease, a debilitating, cognitive, and neurological disorder, gradually erodes a person’s memory, language ...

Novo Nordisk announced Phase 2a trial results for monlunabant. The trial demonstrated a weight reduction of 7.1 kg with a 10 ...

Shares of Roche Holding AG fell after a poster highlighted side effects in an early-stage study of the Swiss pharmaceutical ...